Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker.
Liubomirski Y, Tiram G, Scomparin A, Gnaim S, Das S, Gholap S, Ge L, Yeini E, Shelef O, Zauberman A, Berger N, Kalimi D, Toister-Achituv M, Schröter C, Dickgiesser S, Tonillo J, Shan M, Deutsch C, Sweeney-Lasch S, Shabat D, Satchi-Fainaro R.
Liubomirski Y, et al. Among authors: schroter c.
J Control Release. 2024 Mar;367:148-157. doi: 10.1016/j.jconrel.2024.01.025. Epub 2024 Jan 25.
J Control Release. 2024.
PMID: 38228272